Tests a walking exercise test before lung surgery in people with chronic lung disease
Checks whether a walking test predicts breathlessness after lung removal surgery.
Key facts
- Who runs it
- Seoul National University Bundang Hospital
- Where
- Seongnam-si, South KoreaSee the site
- Trial code
- Registry title
- SWEEP: Shuttle Walking Test for Exercise Evaluation in Pulmonary Resection
- Status
- Recruiting
- People taking part
- 100 people, planned
- Started
- 1 Jun 2025
- Planned end
- 31 May 2026
- Type of study
- Observational
- Record updated
- 4 August 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults aged 40 or older with a chronic lung disease (COPD, ILD or bronchiectasis) who are scheduled for lung surgery. They do a walking test before surgery and answer questionnaires before and after.
- Age
- 40 years or older
- Sex
- All sexes can join.
- Disease stage
- A diagnosis of COPD, ILD or bronchiectasis, with lung resection scheduled (for example for lung cancer or a benign tumor).
Main reasons for not taking part
- Cannot read the study materials
- Cannot communicate in Korean
- Declines or withdraws consent
- Severe leg disability that stops walking (for example a fracture or paralysis)
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- - Age ≥ 40 years
- Scheduled for surgical lung resection (e.g., for lung cancer or benign tumor)
- Diagnosis of chronic respiratory disease (COPD, ILD, or bronchiectasis)
- Able to perform Shuttle Walking Test (ISWT + ESWT) before surgery
- Able to complete pre- and postoperative symptom questionnaires (dyspnea, EQ-5D)
Who cannot take part
- - Illiteracy or inability to read study materials
- Inability to communicate in Korean
- Decline or withdraw consent
- Severe lower limb disability interfering with walking (e.g., fracture, paralysis)
Where in South Korea
- Seoul National University Bundang HospitalSeongnam-si, South KoreaContact: Ye Jin LeeTaking people
About the trial
What the trial wants to find out
This is a prospective observational study that evaluates whether the Shuttle Walking Test (SWT) can predict postoperative symptoms, particularly dyspnea, in patients with chronic respiratory diseases undergoing lung resection.
Read full original descriptionShow less
Currently, tools such as DLCO or cardiopulmonary exercise testing (CPET) are used to assess surgical risk and exercise capacity before lung surgery. However, these tests are not always accessible due to equipment limitations or long waiting times. The SWT is a simpler, safer, and more cost-effective alternative that has been recently recognized as a new medical technology in Korea for evaluating exercise capacity.
In this study, patients with chronic lung diseases (such as COPD, ILD, or bronchiectasis) who are scheduled to undergo lung resection will perform the SWT before surgery. Their symptoms and quality of life will be assessed through questionnaires before and three months after the surgery. The goal is to determine whether SWT results can help predict postoperative dyspnea and provide useful information for preoperative risk stratification.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Predictive Value of the Shuttle Walking Test for Postoperative Dyspnea in Chronic Respiratory Disease Patients Undergoing Lung Resection: A Prospective Observational Study
- Plain-language title
- Tests a walking exercise test before lung surgery in people with chronic lung diseaseGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 4 August 2025